Hilma Biocare Semaglutide 2 mg

Hilma Biocare Semaglutide 2 mg — Weight management

Hilma Biocare Semaglutide 2 mg is a GLP-1 receptor agonist designed to promote weight loss and improve blood sugar control. It’s administered as a weekly subcutaneous injection.

What it does

Semaglutide activates GLP-1 receptors in your body to reduce appetite, increase feelings of fullness, slow how quickly your stomach empties, and improve glucose regulation — all of which support sustainable weight loss.

How to use it

• Dosing schedule: Start at 0.25 mg once weekly, then increase gradually every 4 weeks (0.5 mg, 1.0 mg, 1.7 mg, and finally 2.4 mg). Some users target 2.0 mg instead — dosing can be individualized based on your needs and tolerance.
• Administration: Inject under the skin once per week using sterile technique; follow storage instructions.

Getting the best results

Semaglutide works best when combined with healthy eating and regular exercise. Eat smaller meals and stay well hydrated, especially during the first few weeks when your body is adjusting. Gradual dose increases help minimize nausea and other digestive side effects.

Side effects to expect

Common: Nausea, vomiting, diarrhea, constipation, and decreased appetite — most improve as your body adjusts.

Serious (rare): Severe abdominal pain, persistent vomiting, pancreatitis, gallbladder problems, sudden vision changes, or signs of allergic reaction. Stop use immediately if you experience any of these.

Important safety information

Do not use if you are pregnant or breastfeeding. Use caution if you have a personal or family history of thyroid cancer or MEN2 syndrome. Be aware of potential interactions with other medications and existing health conditions. Stay hydrated to avoid kidney problems from severe vomiting or dehydration.

We recommend using our peptide dosage & reconstitution calculators.